Brief: Medicus Pharma Enters Definitive Agreement To Buy Antev
June 30 (Reuters) - Medicus Pharma Ltd MDCX.O: MEDICUS PHARMA LTD - ENTERS DEFINITIVE AGREEMENT TO BUY ANTEV - SEC FILING MEDICUS PHARMA LTD - TO BUY ANTEV FOR 2.67 MILLION SHARES- SEC FILING MEDICUS PHARMA LTD - ANTEV SHAREHOLDERS TO RECEIVE UP TO $65 MILLION IN CONTINGENT PAYMENTS - SEC FILING Source text: [ID:n0001062993-25-012231] Further company coverage: MDCX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicus Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Medicus Pharma Submits Optimized Teverelix® Registrational Protocol To FDA To Create Partner Ready Program In Advanced Prostate Cancer